Skip to main content
Clinical Trials/NCT04514276
NCT04514276Active, not recruitingNot Applicable

Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway for High-risk Pregnant Women Because of Fetal Growth Restriction

Technische Universität Dresden4 sites in 1 country828 target enrollmentStarted: June 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
828
Locations
4
Primary Endpoint
Evaluation of patients' safety: newborn's birthweight adjusted by gestational age

Study Overview

Brief Summary

Due to the fetoneonatal pathway it is possible to identify pregnant women with an increased risk of fetal growth restriction or pre-eclampsia in early stages (from 10th week of pregnancy). Women whose pregnancy is considered high-risk receives risk-adapted prenatal treatment as well as certain treatments for their newborn and infant until 1 year of age. The tasks of all involved persons are defined by standard operating procedures (SOP)

Detailed Description

By implementing a preventive feto-neonatal pathway, healthcare for pregnant women with high risk of fetal growth restriction (FGR) or pre-eclampsia will be improved and, therefore the occurence of children's health problems may be prevented.The pathway allows healthcare to be structured, ross-sectoral, inter- and multidisciplinary in consideration of medical and psychosocial imensions. The feto-neonatal pathway transfers scientific findings, which already determine international routine care, in the project region into clinical routine care. The anamnestically increased risk for FGR or pre-eclampsia is validated by ultrasound and the identified high-risk pregnancy is attended risk-adapted from birth until the end of the first year of life of the child.As a result, the mothers' pregnancy-related risks (death, premature delivery, traumatic stress disorders) as well as risks for the child (prematurity and associated problems, childhood growth restriction with the risk of metabolic syndrome, developmental neurological problems) are reduced and the sustainability of the interventions is ensured in the long term through improved health competence of the families. The feto-neonatal pathway shows how highly specialised fetoneonatal care of high-risk pregnancies can be ensured while ensuring primary care in a health region, and offers the possibility of being extended to other indications.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female, minim. 10 weeks of pregnancy, maximum 36 weeks of pregnancy
  • anamnestic risk of preeclempsia or fetal growth restriction
  • being part of the project region

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Evaluation of patients' safety: newborn's birthweight adjusted by gestational age

Time Frame: through study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: maternal morbidity

Time Frame: through study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: infantil morbidity

Time Frame: through study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: Quality of life

Time Frame: through study completion, an average of 1 year and 7 months

Questionnaire: Quality of Life (Angermayer, Kilin \& Matschinger, 2000)

Evaluation of patient's access to treatment and satisfaction

Time Frame: through study completion, an average of 1 year and 7 months

self-designed questionnaire

claim of the health services

Time Frame: From admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

Evaluation of patients' safety: maternal pre-eclampsia rate

Time Frame: through study completion, an average of 1 year and 7 months

self-designed questionnaire, health information

Evaluation of patients' safety: attachment behavior

Time Frame: through study completion, an average of 1 year and 7 months

Questionnaire: Postpartum Bonding Questionnaire (Reck et al., 2006)

duration of unemployability

Time Frame: From admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

prohibition of employment

Time Frame: From admission to discharge, study inclusion to one year postpartum)

based on self-designed questionnaires

Secondary Outcomes

  • evaluation of ungoing processes during the fetoneontal health care pathway: effectiveness of fetoneonatal health care(From admission to discharge, study inclusion to one year postpartum)
  • evaluation of ungoing processes during the fetoneontal health care pathway: the pathway's maintenance being long term part of routine health care(From admission to discharge, study inclusion to one year postpartum)
  • evaluation of ungoing processes during the fetoneontal health care pathway: target patients(From admission to discharge, study inclusion to one year postpartum)
  • health economical evaluation(From admission to discharge, study inclusion to one year postpartum)
  • evaluation of ungoing processes during the fetoneontal health care pathway: implementation of participating employees(From admission to discharge, study inclusion to one year postpartum)
  • evaluation of ungoing processes during the fetoneontal health care pathway: participation of health care provider(From admission to discharge, study inclusion to one year postpartum)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials

Inter- and Multidisciplinary,... | Clinical Trial